Contract

Supportive Medicines Phase 5a - Propofol 1g/50ml Emulsion for Infusion

  • Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

F03: Contract award notice

Notice identifier: 2022/S 000-004568

Procurement identifier (OCID): ocds-h6vhtk-031874

Published 17 February 2022, 4:52pm



Section one: Contracting authority

one.1) Name and addresses

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

Nobel House, 17 Smith Square

London

SW1P 3JR

Contact

Simeon Hadebe

Email

dhsc.covidmeds@dhsc.gov.uk

Country

United Kingdom

NUTS code

UKI32 - Westminster

Internet address(es)

Main address

https://www.gov.uk/government/organisations/uk-health-security-agency

Buyer's address

https://www.gov.uk/government/organisations/uk-health-security-agency

one.4) Type of the contracting authority

Ministry or any other national or federal authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Supportive Medicines Phase 5a - Propofol 1g/50ml Emulsion for Infusion

Reference number

CM-EMI-21-C57450

two.1.2) Main CPV code

  • 33600000 - Pharmaceutical products

two.1.3) Type of contract

Supplies

two.1.4) Short description

A requirement for the supply of 375,000 vials of Propofol 1g / 50 ml emulsion for infusion (for use in Intensive Treatment Units) in preparation for further waves of Covid 19 in Winter 2021/Spring 2022.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £1

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom
Main site or place of performance

Haydock, England

two.2.4) Description of the procurement

The Department of Health and Social Care (DHSC) has awarded a contract for the supply of 375,000 vials of Propofol 1g / 50 ml emulsion for infusion (for use in Intensive Treatment Units) in preparation for further waves of Covid 19 in Winter 2021/Spring 2022. The contract was awarded on behalf of United Kingdom Health Security Agency (UKHSA)

two.2.5) Award criteria

Quality criterion - Name: Availability / Weighting: 100

Price - Weighting: 0

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • Extreme urgency brought about by events unforeseeable for the contracting authority

Explanation:

The Coronavirus disease (Covid-19) is a serious infectious respiratory disease and its consequences pose a risk to life. The Covid-19 pandemic supportive medicines stockpile was designed as a ‘one off’ build to target volumes of a defined range of critical products used within the intensive treatment units and end of life environments. However, developments in Winter 2021 around the Omicron variant and heightened risk perception within Government prompted activation of the ‘Challenging Winter Peak’ Scenario at very short notice, resulting in an urgent requirement to procure additional volumes of some critical products to avoid their complete stockout in the month of January 2022. The global stock of Propofol is limited and there are many buyers competing for the same supplies. It is imperative that security of supply is maintained for public health purposes. Due to the short delivery timeframe required to mitigate a complete stockout, the authority did not have sufficient time to comply with the standard open procedure time scales for this procurement. Accordingly, the Authority used the negotiated procedure without prior publication – Regulation 32(2)(c) – Extreme Urgency Route (i.e. direct award) permitted under the Public Contract Regulations 2015 (as amended) to conduct this procurement

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

23 January 2022

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

B. Braun Medical Limited

Thorncliffe Park, Sheffield

Sheffield

S35 2PW

Country

United Kingdom

NUTS code
  • UKE32 - Sheffield
National registration number

2296559

Internet address

http://www.bbraun.co.uk

The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £1

Total value of the contract/lot: £1


Section six. Complementary information

six.3) Additional information

Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per vial. This will (i) commercially prejudice the contracting authority in its commercial dealings with other suppliers; and (ii) impact fair competition between suppliers.

The Contract is for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of Products to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting Products delivered against the contract may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories .

six.4) Procedures for review

six.4.1) Review body

The High Court

Strand

London

WC2A 2LL

Email

generaloffice@administrativecourtoffice.justice.gov.uk

Country

United Kingdom

Internet address

https://www.gov.uk/courts-tribunals